Correlation Engine 2.0
Clear Search sequence regions


  • anemic (1)
  • anti d (10)
  • anti- antibodies (1)
  • birth (1)
  • disease fetus (2)
  • erythroblastosis (1)
  • female (1)
  • fetus (1)
  • globulin (2)
  • humans (1)
  • infant (1)
  • infant newborn (1)
  • newborn (2)
  • patients (1)
  • pregnancy (5)
  • Sizes of these terms reflect their relevance to your search.

    Hemolytic disease of the fetus and newborn (HDFN) is a potentially fatal complication in Rh-incompatible pregnancies and rarely occurs in the sensitizing pregnancy. Distinguishing RhIG from true anti-D identified is challenging. A case of severe HDFN in which a sample drawn at 28 weeks showed anti-D antibody (3+ strength) attributed to RhIG is described. RBC antibody testing early in pregnancy was negative. At birth, the infant was severely anemic and maternal anti-D titer was 1:256. This case represents a clinically significant anti-D in the sensitizing pregnancy that was missed due to confusion with RhIG. To determine if agglutination strength could be helpful, a retrospective chart-review using both electronic and paper medical records was performed on 348 samples identified as RhIG and 52 true anti-D samples. The agglutination strength of antibody was recorded for each sample. For RhIG, there was an even distribution between the weak to moderate agglutination strength (w+, 1+, and 2+) results (35%, 26%, and 33%, respectively) and just 6% had a 3+ strength. Agglutination strength in patients with high titer (≥1:16) anti-D showed they often (44.4%) have 1+ or 2+ agglutination reactivity. These results show that agglutination strength alone does not provide reliable evidence to distinguish RhIG from high titer anti-D antibodies. We recommend that in cases where there is any uncertainty about whether the anti-D reactivity is due to RhIG, titers should be performed to rule out clinically significant anti-D antibody. © 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.

    Citation

    Mackenzie L Walhof, Judith Leon, Andrea L Greiner, James R Scott, Charles Michael Knudson. Hemolytic disease of the fetus and newborn in the sensitizing pregnancy where anti-D was incorrectly identified as RhIG. Journal of clinical laboratory analysis. 2022 Apr;36(4):e24323

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35243688

    View Full Text